Ahmet Özet (Ahmet Ozet)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 33

Top Topics

Locally Advanced

Metastatic Renal Cell Carcinoma

Palliative Care

Top Venues

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Cancer investigation

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci, Osman Sütçüoğlu, Gokhan Ucar, Orhun Akdoğan, Doğan Uncu, Nesrin Turhan, Nalan Akyurek, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer investigation 42 (2) (2024)
Kadriye Bir Yücel, Uguray Aydos, Osman Sütçüoğlu, Atiye Cenay Karabörk Kilic, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors. Cancer chemotherapy and pharmacology 93 (5) (2024)
Kadriye Bir Yücel, Muzaffer Uğraklı, Serhat Sekmek, Nilgun Yıldırım, Fatih Gürler, Ozan Yazıcı, Ahmet Özet, Öznur Bal, Murat Araz, Mustafa Yıldırım, Nuriye Ozdemir
Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study. Current medical research and opinion (2024)
Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci, Osman Sütçüoğlu, Gokhan Ucar, Orhun Akdoğan, Doğan Uncu, Nesrin Turhan, Nalan Akyurek, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer investigation 42 (2) (2024)
Fatih Gürler, Fatih Tay, Zehra Sucuoglu Isleyen, Tahir Yerlikaya, Haci Mehmet Turk, Selin Aktürk Esen, Osman Sütçüoğlu, Deniz Işık, Büşra Niğdelioğlu, Miraç Özen, Elif Sahin, Teoman Sakalar, Nilay Sengul Samanci, Özkan Alan, İlhan Hacıbekiroğlu, Efnan Algin, Melek Karakurt Yılmaz, Hacı Mehmet Türk, Ömür Berna Çakmak Öksüzoğlu, Aydın Yavuz, Osman Yuksel, Hüseyin Bora, Ozan Yazıcı, Ahmet Özet, Nuriye Ozdemir
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study. Cancer medicine 13 (14) (2024)
Fatih Gürler, Fatih Tay, Zehra Sucuoglu Isleyen, Tahir Yerlikaya, Haci Mehmet Turk, Selin Aktürk Esen, Osman Sütçüoğlu, Deniz Işık, Büşra Niğdelioğlu, Miraç Özen, Elif Sahin, Teoman Sakalar, Nilay Sengul Samanci, Özkan Alan, İlhan Hacıbekiroğlu, Efnan Algin, Melek Karakurt Yılmaz, Hacı Mehmet Türk, Ömür Berna Çakmak Öksüzoğlu, Aydın Yavuz, Osman Yuksel, Hüseyin Bora, Ozan Yazıcı, Ahmet Özet, Nuriye Ozdemir
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study. Cancer medicine 13 (14) (2024)
Kadriye Bir Yücel, Uguray Aydos, Osman Sütçüoğlu, Atiye Cenay Karabörk Kilic, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors. Cancer chemotherapy and pharmacology (2024)
Kadriye Bir Yücel, Muzaffer Uğraklı, Serhat Sekmek, Nilgun Yıldırım, Fatih Gürler, Ozan Yazıcı, Ahmet Özet, Öznur Bal, Murat Araz, Mustafa Yıldırım, Nuriye Ozdemir
Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study. Current medical research and opinion (2024)
Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci, Osman Sütçüoğlu, Gokhan Ucar, Orhun Akdoğan, Doğan Uncu, Nesrin Turhan, Nalan Akyurek, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer investigation (2024)
Kadriye Bir Yücel, Muzaffer Uğraklı, Serhat Sekmek, Nilgun Yıldırım, Fatih Gürler, Ozan Yazıcı, Ahmet Özet, Öznur Bal, Murat Araz, Mustafa Yıldırım, Nuriye Ozdemir
Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study. Current medical research and opinion 40 (7) (2024)
Fatih Gürler, Fatih Tay, Zehra Sucuoglu Isleyen, Tahir Yerlikaya, Haci Mehmet Turk, Selin Aktürk Esen, Osman Sütçüoğlu, Deniz Işık, Büşra Niğdelioğlu, Miraç Özen, Elif Sahin, Teoman Sakalar, Nilay Sengul Samanci, Özkan Alan, İlhan Hacıbekiroğlu, Efnan Algin, Melek Karakurt Yılmaz, Hacı Mehmet Türk, Ömür Berna Çakmak Öksüzoğlu, Aydın Yavuz, Osman Yuksel, Hüseyin Bora, Ozan Yazıcı, Ahmet Özet, Nuriye Ozdemir
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study. Cancer medicine 13 (14) (2024)
Kadriye Bir Yücel, Uguray Aydos, Osman Sütçüoğlu, Atiye Cenay Karabörk Kilic, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors. Cancer chemotherapy and pharmacology 93 (5) (2024)
Fatih Gürler, Selin Aktürk Esen, Bediz Kurt İnci, Osman Sütçüoğlu, Gokhan Ucar, Orhun Akdoğan, Doğan Uncu, Nesrin Turhan, Nalan Akyurek, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancer investigation 42 (2) (2024)
Kadriye Bir Yücel, Atiye Cenay Karabörk Kilic, Osman Sütçüoğlu, Ozan Yazıcı, Hüseyin Koray Kılıç, Gözde Savaş, Aytuğ Üner, Nazan Günel, Ahmet Özet, Nuriye Ozdemir
Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy. Journal of chemotherapy (Florence, Italy) (2023)
Kadriye Bir Yücel, Zeynep Irem Ozay, Osman Sütçüoğlu, Ozan Yazıcı, Aytuğ Üner, Nazan Günel, Ahmet Özet, Gözde Savaş, Nuriye Ozdemir
Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (2) (2023)
Kadriye Bir Yücel, Zeynep Irem Ozay, Osman Sütçüoğlu, Ozan Yazıcı, Aytuğ Üner, Nazan Günel, Ahmet Özet, Gözde Savaş, Nuriye Ozdemir
Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (2) (2023)
Görkem Yazıcı Şener, Osman Sütçüoğlu, Betül Oğüt, Deniz Can Guven, Altan Kavuncuoglu, Nuriye Ozdemir, Ahmet Özet, Sercan Aksoy, Yeşim Gaye Güler Tezel, Nalan Akyurek, Ozan Yazıcı
Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)
Orhun Akdoğan, Osman Sütçüoğlu, Ahmet Özet, Ozan Yazıcı, Nuriye Ozdemir
Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (8) (2023)
Kadriye Bir Yücel, Zeynep Irem Ozay, Osman Sütçüoğlu, Ozan Yazıcı, Aytuğ Üner, Nazan Günel, Ahmet Özet, Gözde Savaş, Nuriye Ozdemir
Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (2) (2023)
Kadriye Bir Yücel, Zeynep Irem Ozay, Osman Sütçüoğlu, Ozan Yazıcı, Aytuğ Üner, Nazan Günel, Ahmet Özet, Gözde Savaş, Nuriye Ozdemir
Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 31 (2) (2023)
Kadriye Bir Yücel, Osman Sütçüoğlu, Ozan Yazıcı, Ahmet Özet, Nuriye Ozdemir
Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer. Journal of gastrointestinal cancer (2023)
Volkan Aslan, Atiye Cenay Karabörk Kilic, Ahmet Özet, Aytuğ Üner, Nazan Günel, Ozan Yazıcı, Gözde Savaş, Ahmet Bayrak, Emrah Eraslan, Ömür Berna Çakmak Öksüzoğlu, Hüseyin Koray Kılıç, Nuriye Ozdemir
The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma. BMC cancer 23 (1) (2023)
Osman Sütçüoğlu, Ahmet Özet, Ozan Yazıcı, Nuriye Ozdemir
Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Orhun Akdoğan, Osman Sütçüoğlu, Betül Oğüt, Nalan Akyurek, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer. Immunotherapy 14 (14) (2022)
Ahmet Özet, Faysal Dane, Nuri Faruk Aykan, Şuayib Yalçin, Türkkan Evrensel, Metin Ozkan, Bülent Karabulut, Merve Nur Ormeci, Ozan Atasev, Loïck Vidot, Irfan Cicin
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey. Future oncology (London, England) 18 (29) (2022)
Osman Sütçüoğlu, Nigar Rustamova Cennet, Ahmet Özet, Nuriye Ozdemir, Ozan Yazıcı
Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Volkan Aslan, Osman Sütçüoğlu, Ahmet Özet, Nuriye Ozdemir, Ozan Yazıcı
Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Cengiz Karaçin, Tulay Eren, Esra Zeynelgil, Goksen İnanc İmamoglu, Mustafa Altınbaş, Ibrahim Karadag, Fatma Bugdayci Basal, Hasan Selçuk Özger, Osman Sütçüoğlu, Ozan Yazıcı, Nuriye Ozdemir, Ahmet Özet, Yeşim Yıldız, Selin Aktürk Esen, Gokhan Ucar, Doğan Uncu, Bedia Dinc, Musa Baris Aykan, İsmail Ertürk, Nuri Karadurmus, Burak Civelek, İsmail Çelik, Yakup Ergün, Mutlu Doğan, Ömür Berna Çakmak Öksüzoğlu
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Future oncology (London, England) 17 (33) (2021)
Osman Sütçüoğlu, Ozan Yazıcı, Ahmet Özet
Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment? Future oncology (London, England) 17 (35) (2021)
Neslihan Kayahan Satis, Mustafa Karaca, Hasan Satiş, Dilek Yapar, Ahmet Özet
Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer Turkish journal of medical sciences 51 (4) (2021)
Tuba Uğur, Fatih Gürler, Bülent Cengiz, Reha Kuruoğlu, Ahmet Özet
A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental? Journal of gastrointestinal cancer (2021)
Osman Sütçüoğlu, Ayşegül İlhan, Seher Yildiz Tacar, Deniz Can Guven, Gokhan Ucar, Nuri Karadurmus, Fatih Yildiz, Emrah Eraslan, Doğan Uncu, Deniz Tural, Aytuğ Üner, Nazan Günel, Nuriye Ozdemir, Saadettin Kılıçkap, Ömür Berna Çakmak Öksüzoğlu, Ahmet Özet, Ozan Yazıcı
Thirty-day mortality rates after immunotherapy initiation. Immunotherapy 13 (17) (2021)
Osman Sütçüoğlu, Orhun Akdoğan, Fatih Gürler, Bediz Kurt İnci, Nuriye Ozdemir, Ahmet Özet, Ozan Yazıcı
The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia. International journal of clinical practice 75 (7) (2021)